loading
Oramed Pharmaceuticals Inc stock is traded at $2.29, with a volume of 13,788. It is down -1.18% in the last 24 hours and up +10.22% over the past month. Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.32
Open:
$2.311
24h Volume:
13,788
Relative Volume:
0.19
Market Cap:
$93.90M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
20.82
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
-0.75%
1M Performance:
+10.22%
6M Performance:
-4.08%
1Y Performance:
-7.56%
1-Day Range:
Value
$2.27
$2.3236
1-Week Range:
Value
$2.2655
$2.45
52-Week Range:
Value
$1.82
$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
Name
Oramed Pharmaceuticals Inc
Name
Phone
646-844-1164
Name
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
Employee
13
Name
Twitter
@OramedPharma
Name
Next Earnings Date
2025-08-19
Name
Latest SEC Filings
Name
ORMP's Discussions on Twitter

Compare ORMP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ORMP
Oramed Pharmaceuticals Inc
2.29 95.13M 2.70M 5.53M -10.55M 0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
390.96 100.82B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.88 60.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.83 60.69B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
750.68 46.32B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
326.72 36.58B 3.81B -644.79M -669.77M -6.24

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-12-23 Downgrade Canaccord Genuity Buy → Hold
Feb-18-22 Initiated Cantor Fitzgerald Overweight
Apr-20-21 Initiated Canaccord Genuity Buy
Feb-09-21 Initiated National Securities Buy
Dec-03-20 Initiated Alliance Global Partners Buy
Mar-11-20 Initiated Aegis Capital Buy
Sep-11-19 Initiated Ladenburg Thalmann Buy
Dec-11-17 Resumed B. Riley FBR, Inc. Buy
May-26-16 Reiterated FBR Capital Outperform
Dec-01-15 Reiterated H.C. Wainwright Buy
Nov-19-15 Initiated FBR Capital Outperform
Apr-13-15 Resumed MLV & Co Buy
Jan-30-14 Reiterated Aegis Capital Buy
Jan-08-14 Reiterated Aegis Capital Buy
Jan-08-14 Initiated MLV & Co Buy
Dec-03-13 Initiated Aegis Capital Buy
View All

Oramed Pharmaceuticals Inc Stock (ORMP) Latest News

pulisher
03:19 AM

Does Oramed Pharmaceuticals Inc. stock reflect fundamentals2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک

03:19 AM
pulisher
02:50 AM

Panic Selling: Is Oramed Pharmaceuticals Inc a top pick in the sectorJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک

02:50 AM
pulisher
Sep 15, 2025

Rally Mode: Can Bellevue Life Sciences Acquisition Corp Equity Right scale operations efficiently - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

What Fibonacci levels say about Oramed Pharmaceuticals Inc. reboundMarket Growth Review & Low Drawdown Investment Ideas - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Market Overview: How sensitive is Oramed Pharmaceuticals Inc to inflationJuly 2025 Earnings & Safe Investment Capital Preservation Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Market Recap: What is Oramed Pharmaceuticals Incs 5 year growth outlookExit Point & Real-Time Volume Analysis Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Will Oramed Pharmaceuticals Inc. stock go up soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Technicals: Can Oramed Pharmaceuticals Inc navigate macro headwindsJuly 2025 Setups & Long-Term Safe Investment Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Stock Recap: Is Oramed Pharmaceuticals Inc stock good for income investorsJuly 2025 Price Swings & Stepwise Trade Signal Guides - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

What moving averages say about Oramed Pharmaceuticals Inc.Dip Buying & Long-Term Safe Investment Ideas - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

EV Market: Does FUBO have consistent dividend growthGap Up & Weekly Sector Rotation Insights - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Regression analysis insights on Oramed Pharmaceuticals Inc. performanceJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Market reaction to Oramed Pharmaceuticals Inc.’s recent newsMarket Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

How to read the order book for Oramed Pharmaceuticals Inc.Take Profit & Long-Term Capital Growth Strategies - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to forecast Oramed Pharmaceuticals Inc. trends using time seriesPrice Action & Risk Controlled Daily Trade Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

What the charts say about Oramed Pharmaceuticals Inc. todayJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Tools to monitor Oramed Pharmaceuticals Inc. recovery probabilityPortfolio Gains Report & Risk Controlled Daily Plans - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

How to recover losses in Oramed Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

How moving averages guide Oramed Pharmaceuticals Inc. tradingJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Chart based exit strategy for Oramed Pharmaceuticals Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is Oramed Pharmaceuticals Inc. forming a bottoming baseWeekly Stock Summary & Smart Swing Trading Techniques - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

How to integrate Oramed Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Oramed Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will Oramed Pharmaceuticals Inc. continue its uptrendEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Advanced analytics toolkit walkthrough for Oramed Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Should you hold or exit Oramed Pharmaceuticals Inc. nowBear Alert & Accurate Buy Signal Notifications - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Earnings visualization tools for Oramed Pharmaceuticals Inc.Analyst Downgrade & Daily Price Action Insights - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is Oramed Pharmaceuticals Inc. still worth holding after the dip2025 Risk Factors & AI Powered Market Entry Strategies - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Short Interest & Long-Term Growth Plans - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

What MACD and RSI say about Oramed Pharmaceuticals Inc.2025 Institutional Moves & Short-Term Trading Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

What indicators show strength in Oramed Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Big Picture & Safe Entry Momentum Tips - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIPortfolio Profit Report & Real-Time Buy Zone Alerts - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

What makes Oramed Pharmaceuticals Inc. stock price move sharplyMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Identifying reversal signals in Oramed Pharmaceuticals Inc.Treasury Yields & Safe Capital Growth Tips - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Can volume confirm reversal in Oramed Pharmaceuticals Inc.Inflation Watch & Consistent Return Investment Signals - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Published on: 2025-09-09 17:48:00 - Newser

Sep 10, 2025

Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.42
price up icon 0.75%
$83.87
price up icon 0.94%
$28.18
price up icon 0.63%
$98.91
price up icon 1.04%
$143.31
price up icon 0.10%
biotechnology ONC
$326.80
price down icon 1.63%
Cap:     |  Volume (24h):